Robert Milnes will present Fertility Focus, a device with a mobile interface that can predict fertility windows with great accuracy.
Robert has over 25 years experience in financing and bringing ground-breaking medical technology and software to global markets, with the past 15 years focussed on women’s health. He is CEO of Fertility Focus Limited and Fertility Focus Inc., the company’s wholly owned US subsidiary. Robert has worked for Roche, Oxford Instruments, and was formerly a member of the Operations Board of Huntleigh Healthcare following the successful sale and integration of the Sonicaid Fetal Monitoring and Medilog Cardiology businesses. He has additional extensive experience in general management, sub-contract manufacturing, sales and marketing, and M&A. At Europe 2016, he’ll be demonstrating their app, OvuSense, a realtime fertility monitor.